dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:36:37Z
dc.date.accessioned2022-10-05T13:49:07Z
dc.date.available2014-05-20T13:36:37Z
dc.date.available2022-10-05T13:49:07Z
dc.date.created2014-05-20T13:36:37Z
dc.date.issued2012-07-01
dc.identifierArquivos Brasileiros de Oftalmologia. São Paulo: Consel Brasil Oftalmologia, v. 75, n. 4, p. 235-238, 2012.
dc.identifier0004-2749
dc.identifierhttp://hdl.handle.net/11449/12597
dc.identifier10.1590/S0004-27492012000400002
dc.identifierS0004-27492012000400002
dc.identifierWOS:000312669300002
dc.identifierS0004-27492012000400002.pdf
dc.identifier9420249100835492
dc.identifier8727897080522289
dc.identifier0000-0003-1515-702X
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3888411
dc.description.abstractPurpose: To evaluate the proliferation rate of recurrent pterygium and normal Tenon's capsule fibroblasts after exposure to triamcinolone.Methods: Explants of recurrent pterygia and normal Tenon's capsule of the same carrier were cultured. The fibroblasts were cultured and subcultured until the third passage and subsequently exposed to triamcinolone. The cell proliferation rate was evaluated 3, 6, 12 and 18 days after the exposure.Results: Fibroblasts exposed to triamcinolone had significantly lower proliferation rate (P < 0.05) compared to those not exposed, when the evaluation was performed 3, 6 and 12 days later. In the 18th day after exposure, there was a return in the proliferation rate, with statistical significance, only in the pterigyum fibroblasts.Conclusion: Both the fibroblasts from normal Tenon's capsule as from recurrent pterygia showed significantly lower proliferation rate after exposure to triamcinolone. After 18 days from the exposition, pterygium fibroblasts recovered the proliferation. The results suggested the triamcinolone might be useful as adjuvant in pterygium treatment.
dc.languagepor
dc.publisherConselho Brasileiro de Oftalmologia
dc.relationArquivos Brasileiros de Oftalmologia
dc.relation1.026
dc.relation0,518
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectPterygium/pathology
dc.subjectFibroblasts/pathology
dc.subjectFibroblasts/drug effects
dc.subjectCell culture techniques
dc.subjectCell proliferation/drug effects
dc.subjectRecurrence
dc.subjectTriamcinolone/pharmacology
dc.subjectIn vitro
dc.titleExposição de fibroblastos de pterígios recidivados e da cápsula de Tenon normal à triancinolona
dc.typeArtigo


Este ítem pertenece a la siguiente institución